Laddar populära aktier...
Redeye leaves a brief comment on today's news that Genovis' has launched the second generation of it...
Redeye comments on Active Biotech’s rights issue of SEK35m with a subscription price of SEK 0.
As discussed in our previous update, Crunchfish has now settled on a path forward for the company's ...
Vi inleder bevakning på Premium Snacks Nordic AB, ett svenskt bolag som utvecklar, tillverkar och sä...
Redeye endorses that the FDA has provided positive guidance regarding generic substitutability for I...
Redeye provides a brief comment on Xspray following yesterday's confirmation of the anticipated Q4 2...
Presented a clear and detailed operating blueprint SEK 3.
Mangold uppdaterar sin syn på mobiloperatören My Beat efter det första kvartalet.
Redeye does not believe the underlying value of Hexatronic is 10% less due to Larsson Lyon leaving.
Redeye provides a longer note following WntResearch’s failed phase 2 study and CEO interview.
The 15th MSA agreement suggests that Biovica has secured well over 20 MSA-based projects.
Redeye provides a brief comment on Nordisk Games' divestment of approximately 6.
Redeye comments on the positive ALG.APV-527 data presented at ESMO this weekend.
Redeye briefly comments on the recent management change in Integrum.
Redeye comments on Maximum Entertainment following the demand from CEO, Christina Seelye, and COO, T...